Healthcare mergers and acquisitions are in no short supply as providers, health tech companies, retailers and other industry ...
Naturally, Cigna's bulked-up service offerings should allow it to cross-sell traditional PBM and specialty pharmacy services into its managed-care client set and vice versa, opening up new profit ...
We recently published a list of 10 Best Healthcare Stocks to Buy According to Billionaires. In this article, we are going to ...
LMH Health President and CEO Russ Johnson said he would support Medicare for all despite it being a minority opinion in his ...
The Cigna Group stands poised to reap the rewards of utilization normalization in the back-half of the decade. Specifically, the company is taking steps to reduce exposure to government programs such ...
Cigna is positioned to benefit from utilization normalization and aims for 10%-14% annual EPS growth. See why I rate CI stock a buy at current prices.
Cigna just handed over the Medicare keys to HCSC for a cool $3.3 billion, proving sometimes less is more—especially in ...
T he Cigna Group has completed the sale of its Medicare Advantage, Cigna Supplemental Benefits, Medicare Part D, and ...
The downgrade is based on Moody’s perception that HCSC may encounter difficulties integrating the newly acquired Medicare Advantage (MA) business into its primarily commercial insurance operations.
AstraZeneca signed a deal with Alteogen worth up to $1.35 billion for subcutaneous cancer drugs. Taiho Pharmacetical bought ...
The Cigna Group Completes Sale of Medicare Businesses to HCSC. The Cigna Group. March 19, 2025.
The Cigna Group has completed the sale of its Medicare Advantage, Cigna Supplemental Benefits, Medicare Part D, and CareAllies businesses to Health Care Service Corporation (HCSC).